Clinical Trial Update: RGL-305+ Lymphoma + Exploratory Clinical Study [NA]

View source ↗

Summary

A clinical trial update describes an exploratory study of RGL-305 for lymphoma patients who have complete or partial responses after standard treatment but reta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• RGL-305

Snippet

Sponsor: Fudan University | Conditions: Lymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatment Had a Positive Minimal Residual Lesion (MRD) | NA | Status: RECRUITING